These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 17614975)

  • 1. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
    Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients.
    Carvalho LP; Passos S; Dutra WO; Soto M; Alonso C; Gollob KJ; Carvalho EM; Ribeiro de Jesus A
    Scand J Immunol; 2005 Apr; 61(4):337-42. PubMed ID: 15853916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
    Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
    Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
    Skeiky YA; Guderian JA; Benson DR; Bacelar O; Carvalho EM; Kubin M; Badaro R; Trinchieri G; Reed SG
    J Exp Med; 1995 Apr; 181(4):1527-37. PubMed ID: 7699334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis.
    Rocha PN; Almeida RP; Bacellar O; de Jesus AR; Filho DC; Filho AC; Barral A; Coffman RL; Carvalho EM
    J Infect Dis; 1999 Nov; 180(5):1731-4. PubMed ID: 10515843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis.
    Bomfim G; Nascimento C; Costa J; Carvalho EM; Barral-Netto M; Barral A
    Exp Parasitol; 1996 Nov; 84(2):188-94. PubMed ID: 8932768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.
    Ajdary S; Riazi-Rad F; Alimohammadian MH; Pakzad SR
    J Infect; 2009 Aug; 59(2):139-43. PubMed ID: 19560211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis.
    Bittar RC; Nogueira RS; Vieira-Gonçalves R; Pinho-Ribeiro V; Mattos MS; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Mem Inst Oswaldo Cruz; 2007 Aug; 102(5):625-30. PubMed ID: 17710308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure.
    Brelaz-de-Castro MC; de Almeida AF; de Oliveira AP; de Assis-Souza M; da Rocha LF; Pereira VR
    Cell Immunol; 2012 Oct; 279(2):180-6. PubMed ID: 23246680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania (Viannia) guyanensis induces low immunologic responsiveness in leishmaniasis patients from an endemic area of the Brazilian Amazon Highland.
    Matta NE; Nogueira RS; Franco AM; de Souza E Souza I; Mattos MS; Oliveira-Neto MP; Coutinho SG; Leon LL; Da-Cruz AM
    Am J Trop Med Hyg; 2009 Mar; 80(3):339-44. PubMed ID: 19270278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
    Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
    Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFNG +874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production.
    Matos GI; Covas Cde J; Bittar Rde C; Gomes-Silva A; Marques F; Maniero VC; Amato VS; Oliveira-Neto MP; Mattos Mda S; Pirmez C; Sampaio EP; Moraes MO; Da-Cruz AM
    BMC Infect Dis; 2007 Apr; 7():33. PubMed ID: 17456233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response.
    Farajnia S; Mahboudi F; Ajdari S; Reiner NE; Kariminia A; Alimohammadian MH
    Clin Exp Immunol; 2005 Mar; 139(3):498-505. PubMed ID: 15730396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.
    Carvalho EM; Bacellar O; Brownell C; Regis T; Coffman RL; Reed SG
    J Immunol; 1994 Jun; 152(12):5949-56. PubMed ID: 8207220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and NO in American tegumentary leishmaniasis patients: profiles in active disease, after therapy and in self-healed individuals.
    de Assis Souza M; de Castro MC; de Oliveira AP; de Almeida AF; de Almeida TM; Reis LC; Medeiros ÂC; de Brito ME; Pereira VR
    Microb Pathog; 2013 Apr; 57():27-32. PubMed ID: 23428929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production.
    Leopoldo PT; Machado PR; Almeida RP; Schriefer A; Giudice A; de Jesus AR; Ho JL; Guimarães LH; Bacellar O; Carvalho EM
    BMC Infect Dis; 2006 Apr; 6():75. PubMed ID: 16638143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.
    Valli LC; Passos VM; Dietze R; Callahan HL; Berman JD; Grogl M
    J Parasitol; 1999 Dec; 85(6):1076-83. PubMed ID: 10647040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.